Screening for chronic kidney disease: moving toward more sustainable health care

Current Opinion in Nephrology and Hypertension
Sarah Curtis, Paul Komenda

Abstract

Chronic kidney disease (CKD) is a pervasive and growing health concern that has a significant impact on mortality and morbidity, putting stress on global healthcare systems. CKD affects ∼14% of general populations and ∼36% of high-risk populations and is projected to rise in the coming decade due to increasing rates of diabetes and hypertension. Screen, triage, and treat programs aim to detect early stage disease with the intention of promoting medical and lifestyle interventions in line with a patient's level of risk that may slow disease progression and reduce morbidity and mortality. Early detection facilitates appropriate risk stratification and coordination of care among patients, primary care and nephrology ensuring resources are utilized appropriately. By using readily available laboratory measures, screening for CKD in high-risk populations is cost effective and beneficial to both individuals and healthcare systems. Program models such as Kidney Early Evaluation Program and First Nations Community Based Screening to Improve Kidney Health and Prevent Dialysis have proven the efficacy of screening initiatives in these groups, but improvements are required to maximize the benefits of early CKD detection.

References

Dec 4, 2012·Journal of the American Society of Nephrology : JASN·Thomas J HoergerDesmond E Williams
Apr 10, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Morgan E GramsJosef Coresh
Feb 18, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Paul KomendaNavdeep Tangri
Aug 12, 2015·JAMA : the Journal of the American Medical Association·Milda R SaundersMonica Vela
May 21, 2016·Clinical Journal of the American Society of Nephrology : CJASN·Lauren E GalbraithBrenda R Hemmelgarn
Jan 27, 2017·Journal of Managed Care & Specialty Pharmacy·Leslie WilsonKevin Rodondi
Apr 16, 2017·Seminars in Nephrology·Blake LernerNavdeep Tangri
Apr 24, 2017·Kidney International·Thomas W FergusonPaul V J Komenda
Jun 16, 2018·Bulletin of the World Health Organization·Valerie A LuyckxJohn W Stanifer
Nov 15, 2018·Chinese Medical Journal·Xiao-Xi ZengPing Fu
Apr 16, 2019·Kidney International·Julio Saez-RodriguezRafael Kramann
May 28, 2019·Clinical Chemistry·W Greg MillerJoseph A Vassalotti
Oct 2, 2019·JAMA : the Journal of the American Medical Association·Teresa K ChenMorgan E Grams
Nov 9, 2019·JAMA : the Journal of the American Medical Association·Robert G NelsonUNKNOWN CKD Prognosis Consortium

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Advances in Chronic Kidney Disease
Joseph A VassalottiBryan N Becker
Clinical Journal of the American Society of Nephrology : CJASN
Jeffrey S Berns
Nihon rinsho. Japanese journal of clinical medicine
Toshiki Moriyama
Pragmatic and Observational Research
Simon Fraser, Tom Blakeman
© 2021 Meta ULC. All rights reserved